Literature DB >> 18562487

Fonsecaea pedrosoi infection induces differential modulation of costimulatory molecules and cytokines in monocytes from patients with severe and mild forms of chromoblastomycosis.

Maria Glória Teixeira Sousa1, Conceição de Maria Pedrozo e Silva Azevedo, Rosana Cicera Nascimento, Eliver Eid Bou Ghosn, Karla Leticia Santiago, Vanessa Noal, Gisele Facholi Bomfim, Sirlei Garcia Marques, Azizedite Guedes Gonçalves, Daniel Wagner de Castro Lima Santos, Sandro Rogerio Almeida.   

Abstract

The host defense mechanism in chromoblastomycosis has not been thoroughly investigated. It has been suggested that cell-mediated immunity in patients with long-standing chromoblastomycosis is somehow impaired. As a result, these individuals became unable to develop an efficient immune reaction. Many studies have shown that monocyte-derived macrophages exhibit critical activities in immunity to microorganisms. Moreover, the ability of cells from the monocytic lineage to process and present antigens, to produce cytokines, and to provide costimulatory signals confirms their pivotal role in the initiation of specific immune responses. In the present study, it was observed that monocytes from patients with a severe form of disease had a higher production of IL-10 and a lower expression of HLA-DR and costimulatory molecules when stimulated with specific antigen or LPS. Immune modulation with recombinant IL-12 or anti-IL-10 can restore the antigen-specific Th1-type immune response in chromoblastomycosis patients by up-regulating HLA-DR and costimulatory molecules in monocytes. Therefore, our data show that monocytes from patients with different clinical forms of chromoblastomycosis present distinct phenotypic and functional profiles. This observation suggests possible mechanisms that control the T cell response and influence their role in the development of pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562487     DOI: 10.1189/jlb.0308211

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

Review 1.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis.

Authors:  Alexandre Paulo Machado; Maria Regina Regis Silva; Olga Fischman
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Topical application of imiquimod as a treatment for chromoblastomycosis.

Authors:  Maria da Glória Teixeira de Sousa; Walter Belda; Ricardo Spina; Priscila Ramos Lota; Neusa Sakai Valente; Gordon D Brown; Paulo Ricardo Criado; Gil Benard
Journal:  Clin Infect Dis       Date:  2014-03-14       Impact factor: 9.079

4.  The Efficacy of Humanized Antibody against the Sporothrix Antigen, gp70, in Promoting Phagocytosis and Reducing Disease Burden.

Authors:  José R F de Almeida; Karla L Santiago; Gilberto H Kaihami; Andrea Q Maranhão; Marcelo de Macedo Brígido; Sandro R de Almeida
Journal:  Front Microbiol       Date:  2017-03-03       Impact factor: 5.640

Review 5.  Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.

Authors:  Arival Cardoso de Brito; Maraya de Jesus Semblano Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

Review 6.  Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers.

Authors:  Anne-Lise Bienvenu; Stephane Picot
Journal:  Molecules       Date:  2020-06-02       Impact factor: 4.411

Review 7.  Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis.

Authors:  Leandro C D Breda; Isabela G Menezes; Larissa N M Paulo; Sandro Rogério de Almeida
Journal:  J Fungi (Basel)       Date:  2020-12-22

8.  Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-γ production.

Authors:  Bilin Dong; Zhongsheng Tong; Ruoyu Li; Sharon C-A Chen; Weihuang Liu; Wei Liu; Yao Chen; Xu Zhang; Yiqun Duan; Dongsheng Li; Liuqing Chen
Journal:  PLoS Negl Trop Dis       Date:  2018-02-26

9.  Fonsecaea pedrosoi Conidia and Hyphae Activate Neutrophils Distinctly: Requirement of TLR-2 and TLR-4 in Neutrophil Effector Functions.

Authors:  Leandro Carvalho Dantas Breda; Cristiane Naffah de Souza Breda; José Roberto Fogaça de Almeida; Larissa Neves Monteiro Paulo; Grasielle Pereira Jannuzzi; Isabela de Godoy Menezes; Renata Chaves Albuquerque; Niels Olsen Saraiva Câmara; Karen Spadari Ferreira; Sandro Rogério de Almeida
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

10.  Muriform Cells Can Reproduce by Dividing in an Athymic Murine Model of Chromoblastomycosis due to Fonsecaea pedrosoi.

Authors:  Bilin Dong; Wei Liu; Ruoyu Li; Yao Chen; Zhongsheng Tong; Xu Zhang; Liuqing Chen; Dongsheng Li
Journal:  Am J Trop Med Hyg       Date:  2020-06-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.